3 studies found for:    22296077 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65;   Drug: Placebo
2 Enrolling by invitation Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies
Conditions: Diabetes Mellitus, Type 1;   Prediabetic State
Interventions: Drug: Alum-GAD;   Drug: Vitamin D3
3 Terminated A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65;   Drug: Placebo

Indicates status has not been verified in more than two years